| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-27 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $4.74B | $4.82B | $5.30B |
| YoY Revenue Growth % | -1.6% | -9.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $151.6M | $248.9M | $344.1M |
| Operating Margin % | 3.2% | 5.2% | 6.5% |
| Net Income (GAAP) | $115.0M | $195.9M | $264.4M |
| EBITDA (Normalized) | $159.5M | $273.7M | $535.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $224.9M | $286.6M | $393.6M |
| Capital Expenditures (CapEx) | $9.9M | $31.0M | $238.6M |
| Free Cash Flow (FCF) | $215.0M | $255.6M | $155.0M |
| FCF Margin % | 4.5% | 5.3% | 2.9% |
| Return on Invested Capital (ROIC %) | 15.3% | 22.3% | 7.1% |
| Cash & Short-Term Equivalents | $396.7M | $515.0M | — |
| Total Debt (Short + Long Term) | $382.8M | $424.3M | $1.49B |
| Total Stockholders' Equity | $795.7M | $972.4M | $3.05B |